| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $126K | -2.1% |
| SG&A Expense | $146K | -82.1% |
| Operating Income | -$811K | +28.5% |
| Interest Expense | $128K | +79.4% |
| Net Income | -$935K | +43.4% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20K | -84.2% |
| Current Assets | $29K | -79.6% |
| Total Assets | $62K | -64.4% |
| Current Liabilities | $2.8M | +16.0% |
| Total Liabilities | $2.8M | +16.0% |
| Stockholders' Equity | -$2.8M | -19.8% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$247K | +76.3% |
| Investing Cash Flow | -$35K | — |
| Financing Cash Flow | $288K | -75.2% |